Evidence map›Paper›PMID 41692874›Full record

ArticleCEN case reports2026

An autopsy-proven case of normotensive scleroderma renal crisis with refractory pleuroperitoneal effusion.

Hideki Uedono, Katsuhito Mori, Shinya Nakatani, Kohei Watanabe, Masahiko Furuya, Fumiyuki Morioka, Kazuma Sone, Yuya Miki, Akihiro Tsuda, Sayaka Tanaka and 3 more

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hideki UedonoDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan. uedono1217@omu.ac.jp.
Katsuhito MoriDepartment of Nephrology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Shinya NakataniDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Kohei WatanabeDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Masahiko FuruyaDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Fumiyuki MoriokaDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Kazuma SoneDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Yuya MikiDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Akihiro TsudaDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Sayaka TanakaDepartment of Pathology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Tomoaki MoriokaDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
Kenichi KohashiDepartment of Pathology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Masanori EmotoDepartment of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionScleroderma renal crisis (SRC) is a serious complication of systemic sclerosis that typically presents with hypertension and acute kidney injury (AKI). However, about 10% of cases are normotensive, while refractory pleural or ascitic effusion preceding SRC is rare in clinical practice. Here, we present a case of normotensive SRC preceded by refractory pleural and ascitic effusions. CASE PRESENTATION: The patient was a 66-year-old woman with a history of rheumatoid arthritis who was managed as an outpatient. Three months prior to admission, she developed sudden, generalized refractory pleural and ascitic effusions; however, the cause remained unknown and there was no improvement. Subsequently, she developed AKI and was transferred to our hospital. Hemodialysis was initiated, but despite efforts to reduce dry weight, transudative pleural effusion persisted. The patient was positive for anti-SCL-70 antibodies, but had no hypertension, and a kidney biopsy could not be performed. She later developed pneumonia and ultimately died of respiratory failure caused by pneumonia and pleural effusion. An autopsy revealed widespread fibrosis in multiple organs and marked intimal thickening and stenosis of the vasculature, leading to a diagnosis of normotensive SRC.

conclusionIt is important to consider normotensive SRC as a potential cause of refractory transudative pleural and ascitic effusions resistant to treatment with hemodialysis associated with AKI.

Indexed as

Acute Kidney InjuryPleural EffusionScleroderma, SystemicAgedAutopsyFatal OutcomeFemaleHumansRenal DialysisEffusionNormotensiveScleroderma renal crisis

Identifiers

PMID41692874
PMCPMC12907291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.